[go: up one dir, main page]

WO1996033723A3 - Utilisation de derives benzamides pour traiter et/ou prevenir le syndrome de meniere et le mal des transports - Google Patents

Utilisation de derives benzamides pour traiter et/ou prevenir le syndrome de meniere et le mal des transports Download PDF

Info

Publication number
WO1996033723A3
WO1996033723A3 PCT/JP1996/001112 JP9601112W WO9633723A3 WO 1996033723 A3 WO1996033723 A3 WO 1996033723A3 JP 9601112 W JP9601112 W JP 9601112W WO 9633723 A3 WO9633723 A3 WO 9633723A3
Authority
WO
WIPO (PCT)
Prior art keywords
meniere
syndrome
treating
preventing
motion sickness
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP1996/001112
Other languages
English (en)
Other versions
WO1996033723A2 (fr
Inventor
Masayuki Ishie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Priority to JP8524148A priority Critical patent/JPH11503721A/ja
Publication of WO1996033723A2 publication Critical patent/WO1996033723A2/fr
Publication of WO1996033723A3 publication Critical patent/WO1996033723A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Utilisation d'un composé de la formule (I), dans laquelle chaque symbole est tel que défini dans la description, ou du sel pharmaceutiquement acceptable de ce composé, pour le traitement et/ou la prévention du syndrome de Ménière ou du mal des transports.
PCT/JP1996/001112 1995-04-28 1996-04-24 Utilisation de derives benzamides pour traiter et/ou prevenir le syndrome de meniere et le mal des transports Ceased WO1996033723A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8524148A JPH11503721A (ja) 1995-04-28 1996-04-24 ベンズアミド誘導体の新規用途

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9508637.7 1995-04-28
GBGB9508637.7A GB9508637D0 (en) 1995-04-28 1995-04-28 New use

Publications (2)

Publication Number Publication Date
WO1996033723A2 WO1996033723A2 (fr) 1996-10-31
WO1996033723A3 true WO1996033723A3 (fr) 1997-01-30

Family

ID=10773666

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP1996/001112 Ceased WO1996033723A2 (fr) 1995-04-28 1996-04-24 Utilisation de derives benzamides pour traiter et/ou prevenir le syndrome de meniere et le mal des transports

Country Status (3)

Country Link
JP (1) JPH11503721A (fr)
GB (1) GB9508637D0 (fr)
WO (1) WO1996033723A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7351709B2 (en) 2004-06-09 2008-04-01 Wyeth Estrogen receptor ligands
US9096546B2 (en) 2007-05-10 2015-08-04 Albany Molecular Research, Inc. Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
EP2520561B1 (fr) 2007-06-08 2016-02-10 MannKind Corporation Inhibiteurs IRE-1A
RU2720237C2 (ru) 2013-11-18 2020-04-28 Форма Терапеутикс, Инк. Композиции, содержащие бензопиперазин, в качестве ингибиторов бромодоменов вет
PT3071203T (pt) 2013-11-18 2021-03-11 Forma Therapeutics Inc Composições de tetra-hidroquinolina como inibidores de bromodomínio bet

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0620216A1 (fr) * 1993-04-13 1994-10-19 Fujisawa Pharmaceutical Co., Ltd. Dérives de benzamide et leur utilisation comme antagonistes de vasopressine

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0620216A1 (fr) * 1993-04-13 1994-10-19 Fujisawa Pharmaceutical Co., Ltd. Dérives de benzamide et leur utilisation comme antagonistes de vasopressine

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
A. KAKIGI ET AL.: "Antiduretic hormone (ADH) in patients with Meniere's disease.", EQUILIB. RES. SUPPL., no. 10, 1994, pages 91 - 94, XP000612759 *
L. NAFTALIN ET AL.: "The possible role of hormones and enzymes in the production of the acute attack in Meniere's disease.", EUR. ARCH. OTO-RHINO-LARINGOL., vol. 251, no. 3, pages 173 - 177, XP000612747 *
T. TAKEDA ET AL.: "Plasma antidiuretic hormone in patients with delayed endolymphatic hydrops.", EQUILIB. RES. SUPPL., no. 10, 1994, pages 95 - 100, XP000612758 *

Also Published As

Publication number Publication date
JPH11503721A (ja) 1999-03-30
WO1996033723A2 (fr) 1996-10-31
GB9508637D0 (en) 1995-06-14

Similar Documents

Publication Publication Date Title
IL136044A (en) 2-aminoacetamide derivatives and pharmaceutical compositions containing the same
EP0423714A3 (en) Hair revitalizing agent
IL132107A0 (en) Substituted phenyl derivatives their preparation and use
WO2001066564A3 (fr) Inhibiteurs de gamma-sécrétase
CA2132098A1 (fr) Imizadoles antimicrobiens pour regulariser la secretion sebacee de la peau
EP0828485A4 (fr) Utilisation de r-enantiomere de n-propargyl-1-aminoindane, de sels et de compositions de celui-ci
PL323152A1 (en) Derivatives of 1,3-propanodiole as biologically active compounds
CA2210258A1 (fr) Inhibiteurs de la calpaine et/ou de la cathepsine b derives d'oxazolidine substituee
WO2002000209A3 (fr) Analogues de gabapentine pour traiter les troubles du sommeil
SE9603669D0 (sv) New combination
EP0990648A4 (fr) Derives de 4-quinolinol et bactericides pour l'agriculture et l'horticulture contenant lesdits derives comme principe actif
CA2183315A1 (fr) Nouveaux derives bisulfure de mercaptoacetylamido 1,3,4,5-tetrahydro-benzo[c]azepine-3-one utiles en tant qu'inhibiteurs de l'enkephalinase et de l'enzyme de conversion de l'angiotensine
IL117656A (en) Pharmaceutical compositions comprising a supported saccharide for the treatment of travellers' diarrhea caused by E.coli LT enterotoxin
HU9700060D0 (en) New compound, it's production and it's use as active component of a medicine
WO1996033723A3 (fr) Utilisation de derives benzamides pour traiter et/ou prevenir le syndrome de meniere et le mal des transports
CA2364258A1 (fr) 3-cyclopropylmethoxy-4-difluoromethoxy-n-(3,5-dichloropyrid-4-yl)benzamide pour le traitement de la sclerose en plaques
CA2353205A1 (fr) Agent de traitement de la maladie de parkinson comprenant un ingredient actif sous la forme d'un agent ameliorant la fonction des astrocytes
TW349864B (en) Use of N-(pyridinyl)-1H-indol-a-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders
AU2003263978A1 (en) 2',3'-dideoxynucleoside analogues for the treatment or prevention of flavivitridae infections
GB9513750D0 (en) Use of allylamines
AU2149797A (en) Therapeutic agents for asthma
WO2000002877A3 (fr) Nouveaux composes pharmaceutiques
UA29461C2 (uk) Засіб для лікування амілоїдозу, спосіб лікування амілоїдозу
CA2179634A1 (fr) Analgesiques a base de 4-arylisoindole
HU9502509D0 (en) Use of 1,4-dihydropyridine-3,5-dicarboxylic-acid-esters as active component of pharmaceutical compositions

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref country code: JP

Ref document number: 1996 524148

Kind code of ref document: A

Format of ref document f/p: F

AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase